Murray J S, Hinchliffe W T, Kanagasundaram N S
Department of Renal Medicine, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne NE7 7DN.
Br J Hosp Med (Lond). 2009 Dec;70(12):M189-91. doi: 10.12968/hmed.2009.70.Sup12.45521.
The term renal replacement therapy incorporates three modalities that control or correct biochemical and fluid disturbances of renal failure. Peritoneal dialysis and renal transplantation are two forms of renal replacement therapy that are outside the remit of this article. This review focuses upon the third group which are blood-based and involve direct treatment of a patient's blood in a closed, extracorporeal circuit. They provide renal replacement for end-stage renal failure and during periods of severe acute kidney injury, and also for non-renal indications such as the management of drug overdoses. Blood-based renal replacement therapies are often loosely referred to as 'haemodialysis', although this is only one of a range of treatments. This article outlines the theory and practical applications of these treatments.
肾脏替代疗法这一术语包含三种控制或纠正肾衰竭生化及液体紊乱的方式。腹膜透析和肾移植是不在本文讨论范围内的两种肾脏替代疗法形式。本综述聚焦于第三种类型,即基于血液的疗法,它涉及在封闭的体外循环中直接处理患者的血液。它们为终末期肾衰竭以及严重急性肾损伤期间提供肾脏替代治疗,也用于诸如药物过量处理等非肾脏适应症。基于血液的肾脏替代疗法通常被宽泛地称为“血液透析”,尽管这只是一系列治疗方法中的一种。本文概述了这些治疗方法的理论及实际应用。